Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 12 studies | 33% ± 14% | |
| oligodendrocyte | 11 studies | 35% ± 13% | |
| GABAergic neuron | 10 studies | 43% ± 22% | |
| glutamatergic neuron | 10 studies | 46% ± 23% | |
| endothelial cell | 10 studies | 29% ± 9% | |
| microglial cell | 9 studies | 29% ± 11% | |
| fibroblast | 8 studies | 24% ± 8% | |
| oligodendrocyte precursor cell | 8 studies | 35% ± 14% | |
| adipocyte | 7 studies | 24% ± 6% | |
| mast cell | 6 studies | 24% ± 7% | |
| T cell | 6 studies | 21% ± 5% | |
| endothelial cell of lymphatic vessel | 6 studies | 25% ± 6% | |
| pericyte | 6 studies | 21% ± 6% | |
| macrophage | 5 studies | 31% ± 2% | |
| interneuron | 5 studies | 55% ± 24% | |
| cardiac muscle cell | 4 studies | 22% ± 2% | |
| Mueller cell | 4 studies | 22% ± 2% | |
| amacrine cell | 4 studies | 23% ± 4% | |
| retinal cone cell | 4 studies | 26% ± 6% | |
| retinal rod cell | 4 studies | 23% ± 4% | |
| monocyte | 4 studies | 25% ± 4% | |
| B cell | 4 studies | 25% ± 6% | |
| smooth muscle cell | 4 studies | 24% ± 5% | |
| neuron | 3 studies | 41% ± 14% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 6% | |
| epithelial cell | 3 studies | 30% ± 13% | |
| GABAergic amacrine cell | 3 studies | 21% ± 5% | |
| glycinergic amacrine cell | 3 studies | 21% ± 1% | |
| myeloid cell | 3 studies | 23% ± 4% | |
| ependymal cell | 3 studies | 28% ± 10% | |
| ciliated cell | 3 studies | 24% ± 7% | |
| natural killer cell | 3 studies | 21% ± 4% | |
| type I pneumocyte | 3 studies | 22% ± 4% | |
| type II pneumocyte | 3 studies | 20% ± 4% | |
| lymphocyte | 3 studies | 37% ± 5% | |
| granule cell | 3 studies | 35% ± 3% | |
| dendritic cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1969.78 | 1445 / 1445 | 100% | 21.24 | 183 / 183 |
| prostate | 100% | 2229.62 | 245 / 245 | 100% | 21.86 | 502 / 502 |
| breast | 100% | 2706.78 | 459 / 459 | 99% | 23.09 | 1112 / 1118 |
| stomach | 100% | 1506.76 | 358 / 359 | 100% | 16.79 | 285 / 286 |
| intestine | 100% | 2315.39 | 966 / 966 | 99% | 14.47 | 523 / 527 |
| ovary | 100% | 2873.90 | 180 / 180 | 99% | 14.94 | 426 / 430 |
| lung | 100% | 1850.34 | 577 / 578 | 99% | 14.24 | 1146 / 1155 |
| thymus | 100% | 2670.82 | 653 / 653 | 99% | 19.61 | 599 / 605 |
| skin | 100% | 2393.24 | 1809 / 1809 | 97% | 15.30 | 460 / 472 |
| pancreas | 99% | 1131.75 | 325 / 328 | 98% | 12.47 | 175 / 178 |
| bladder | 100% | 2516.67 | 21 / 21 | 97% | 10.65 | 490 / 504 |
| brain | 98% | 1773.72 | 2577 / 2642 | 100% | 14.62 | 702 / 705 |
| uterus | 100% | 2986.69 | 170 / 170 | 95% | 10.21 | 437 / 459 |
| kidney | 98% | 1149.24 | 87 / 89 | 95% | 14.03 | 855 / 901 |
| adrenal gland | 97% | 1268.70 | 251 / 258 | 95% | 12.44 | 218 / 230 |
| liver | 95% | 687.77 | 215 / 226 | 80% | 6.31 | 325 / 406 |
| adipose | 100% | 2581.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2810.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.14 | 29 / 29 |
| spleen | 100% | 2211.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.31 | 1 / 1 |
| muscle | 100% | 1251.96 | 800 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1907.89 | 905 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 12.17 | 77 / 80 |
| heart | 95% | 1070.00 | 815 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 12.22 | 42 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045596 | Biological process | negative regulation of cell differentiation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0140288 | Cellular component | GBAF complex |
| GO_0016514 | Cellular component | SWI/SNF complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BICRAL |
| Protein name | BRD4-interacting chromatin-remodeling complex-associated protein-like (Glioma tumor suppressor candidate region gene 1 protein-like) |
| Synonyms | KIAA0240 GLTSCR1L |
| Description | FUNCTION: Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. . |
| Accessions | Q6AI39 ENST00000394168.1 ENST00000314073.10 |